Understanding the Influences of COPD Patient's Capability on the Uptake of Pulmonary Rehabilitation in the UK Through an Inclusive Design Approach.

COPD Inclusive Design capability care journey healthcare access pulmonary rehabilitation

Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2021
Historique:
received: 05 02 2021
accepted: 19 04 2021
entrez: 25 6 2021
pubmed: 26 6 2021
medline: 12 8 2021
Statut: epublish

Résumé

Pulmonary rehabilitation (PR) is recommended for patients with COPD to improve their symptoms and quality of life. However, in the UK, only one in ten of those who need PR receive it and this might be inaccessible to people with disabilities. This study aims to inform improvements to PR service by identifying barriers to the uptake of PR in the COPD care journey in relation to patients' capabilities that can affect their access to PR. An Inclusive Design approach with mixed methods was undertaken. Firstly, patients and healthcare professionals were interviewed to gather insight into their experiences of COPD care and map patients' care journey. Secondly, an Exclusion Calculator was used to estimate service demand on patients' capability and the proportion of population excluded from the service. Thirdly, a framework analysis was applied to guide data analysis to identify the challenges of accessing PR. Finally, proposed recommendations were refined with patients and healthcare professionals. The overall capability-related exclusion number was very high (62.5%), and exclusion caused by limited mobility was the highest (50%) among the interviewees and even higher based on the population database. This suggests the importance of considering COPD patients' capability-related needs to improve their access to care. Capability-related challenges for patients accessing PR such as poor mobility to transport and low vision impairing ability to read inhaler instructions were identified, as well as non-capability-related challenges such as patients' perception about COPD and inability to access proper information. Recommendations were proposed to help patients to self-manage their COPD and access to PR. Lack of attention to COPD patients' capability level in the delivery of PR may affect its uptake. Considering the capability-related needs of COPD patients and providing patients with reassurance, information, and support on their care journey could improve the uptake of PR.

Sections du résumé

Background
Pulmonary rehabilitation (PR) is recommended for patients with COPD to improve their symptoms and quality of life. However, in the UK, only one in ten of those who need PR receive it and this might be inaccessible to people with disabilities. This study aims to inform improvements to PR service by identifying barriers to the uptake of PR in the COPD care journey in relation to patients' capabilities that can affect their access to PR.
Methods
An Inclusive Design approach with mixed methods was undertaken. Firstly, patients and healthcare professionals were interviewed to gather insight into their experiences of COPD care and map patients' care journey. Secondly, an Exclusion Calculator was used to estimate service demand on patients' capability and the proportion of population excluded from the service. Thirdly, a framework analysis was applied to guide data analysis to identify the challenges of accessing PR. Finally, proposed recommendations were refined with patients and healthcare professionals.
Results
The overall capability-related exclusion number was very high (62.5%), and exclusion caused by limited mobility was the highest (50%) among the interviewees and even higher based on the population database. This suggests the importance of considering COPD patients' capability-related needs to improve their access to care. Capability-related challenges for patients accessing PR such as poor mobility to transport and low vision impairing ability to read inhaler instructions were identified, as well as non-capability-related challenges such as patients' perception about COPD and inability to access proper information. Recommendations were proposed to help patients to self-manage their COPD and access to PR.
Conclusion
Lack of attention to COPD patients' capability level in the delivery of PR may affect its uptake. Considering the capability-related needs of COPD patients and providing patients with reassurance, information, and support on their care journey could improve the uptake of PR.

Identifiants

pubmed: 34168438
doi: 10.2147/COPD.S305145
pii: 305145
pmc: PMC8217842
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1717-1740

Informations de copyright

© 2021 Liu et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J Cardiopulm Rehabil Prev. 2012 Nov-Dec;32(6):359-69
pubmed: 22941449
Lancet. 2017 Sep 2;390(10098):980-987
pubmed: 28872030
Appl Ergon. 2019 Nov;81:102876
pubmed: 31422257
J Glob Health. 2015 Dec;5(2):020415
pubmed: 26755942
ERJ Open Res. 2020 Feb 17;6(1):
pubmed: 32083112
Lancet. 2000 Jan 29;355(9201):362-8
pubmed: 10665556
Thorax. 2016 Nov;71(11):988-995
pubmed: 27293209
Appl Ergon. 2015 Jan;46 Pt B:235-47
pubmed: 23570838
Thorax. 2010 May;65(5):423-8
pubmed: 20435864
Lancet Respir Med. 2017 Sep;5(9):747-759
pubmed: 28601554
J Physiother. 2017 Apr;63(2):84-93
pubmed: 28433238
Int J Chron Obstruct Pulmon Dis. 2018 Oct 29;13:3571-3586
pubmed: 30464439
Eur Respir J. 2013 Nov;42(5):1169-74
pubmed: 24178930
Int J Chron Obstruct Pulmon Dis. 2008;3(2):311-7
pubmed: 18686740
Aust J Rural Health. 2012 Aug;20(4):200-7
pubmed: 22827428
BMJ Open. 2018 Apr 24;8(4):e020750
pubmed: 29691248
BMC Res Notes. 2012 Nov 23;5:652
pubmed: 23176312
Nurse Res. 2011;18(2):52-62
pubmed: 21319484
Appl Ergon. 2014 Jul;45(4):886-94
pubmed: 24456896
Scand J Caring Sci. 2016 Sep;30(3):432-41
pubmed: 26426088
Int J Chron Obstruct Pulmon Dis. 2008;3(1):11-29
pubmed: 18488426
Respir Med. 2012 Mar;106(3):374-81
pubmed: 22000501
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
Chron Respir Dis. 2011;8(2):89-99
pubmed: 21596892
Am J Med. 2005 Dec;118(12):1415
pubmed: 16378794

Auteurs

Yuanyuan Liu (Y)

Department of Industrial Design, School of Mechanical Engineering & Automation, Beihang University, 37 Xueyuan Road, Haidian District, Beijing, 100191, China.
Engineering Design Centre, Department of Engineering, University of Cambridge, Cambridge, CB2 1PZ, UK.

Terry Dickerson (T)

Engineering Design Centre, Department of Engineering, University of Cambridge, Cambridge, CB2 1PZ, UK.

Frances Early (F)

Centre for Self Management Support, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.

Jonathan Fuld (J)

Centre for Self Management Support, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.

Chen Jiang (C)

Department of Clinical Neurosciences, University of Cambridge, Clifford Allbutt Building, Cambridge Biomedical Campus, Cambridge, CB2 0AH, UK.

P John Clarkson (PJ)

Engineering Design Centre, Department of Engineering, University of Cambridge, Cambridge, CB2 1PZ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH